Cargando…
Pulmonary Lymphoepithelioma-Like Carcinoma Treated with Immunotherapy or Chemotherapy: A Single Institute Experience
BACKGROUND: Lymphoepithelioma-like carcinoma (LELC) is a rare malignant tumor of the lung. It is related to EB virus infection. Epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) are rarely found in this disease, while high level programmed cell death ligand 1 (PD-L1) expre...
Autores principales: | Fu, Yang, Zheng, Yue, Wang, Pei-Pei, Chen, Yue-Yun, Ding, Zhen-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897714/ https://www.ncbi.nlm.nih.gov/pubmed/33628032 http://dx.doi.org/10.2147/OTT.S290113 |
Ejemplares similares
-
Comparison of Immunotherapy, Chemotherapy, and Chemoimmunotherapy in Advanced Pulmonary Lymphoepithelioma-Like Carcinoma: A Retrospective Study
por: Xiao, Yi, et al.
Publicado: (2022) -
Clinical observation of pulmonary lymphoepithelioma-like carcinoma
por: Sha, Zhou, et al.
Publicado: (2021) -
Primary pulmonary lymphoepithelioma‐like carcinoma treated with immunotherapy: A case report and literature review
por: Archwamety, Anita, et al.
Publicado: (2022) -
Unusual presentation of pulmonary lymphoepithelioma‐like carcinoma
por: Oi, Ryoko, et al.
Publicado: (2016) -
Primary pulmonary lymphoepithelioma-like carcinoma in Singapore
por: Tay, Chee Kiang, et al.
Publicado: (2018)